Weiss Multi-Strategy Advisers’s Acura Pharmaceuticals ACUR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-13,000	Closed	-$95K	–	1054
2014 Q1	$95K	Sell	13,000 -2,000	-13%	-$17.4K	﹤0.01%	936
2013 Q4	$125K	Sell	15,000 -5,000	-25%	-$42.2K	﹤0.01%	929
2013 Q3	$190K	Hold	20,000	–	–	﹤0.01%	872
2013 Q2	$188K	Buy	+20,000	New	+$226K	0.01%	718

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ACUR Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of Acura Pharmaceuticals (ACUR) in Q2 2014, closing a stake of 13,000 shares — an estimated $95K sold.

Weiss Multi-Strategy Advisers first reported a position in ACUR in Q2 2013 and held it in 4 quarters. The position peaked at $190K in Q3 2013. 33 funds tracked by Wall St. Rank hold ACUR as of Q2 2014.

Weiss Multi-Strategy Advisers reported no remaining Acura Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 13,000 Acura Pharmaceuticals shares in Q2 2014, an estimated $95K.
Weiss Multi-Strategy Advisers first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Weiss Multi-Strategy Advisers's Acura Pharmaceuticals position peaked at $190K in Q3 2013.
33 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.